Actively Recruiting
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
Led by EuMelaReg gGmbH · Updated on 2025-03-12
1300
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.
CONDITIONS
Official Title
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 618 years at index date
- Patients documented in the European NMSC-registry fulfilling EMR quality standard
- Patients with resected high-risk cutaneous squamous cell carcinoma (HR-cSCC) receiving only postoperative radiotherapy or watchful waiting
- Patients with advanced cSCC not candidates for curative surgery or radiation in routine clinical practice
- Patients with advanced basal cell carcinoma (BCC) not candidates for curative surgery or radiation in routine clinical practice
You will not qualify if you...
- Patients receiving treatment within a clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ (Universitair Ziekenhuis) Brüssel
Brussels, Belgium
Actively Recruiting
Research Team
A
Alexandra Hansen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here